Healthcare Stocks News 3 October 2025

Merck & Co. (MRK) Stock News Today: Keytruda Wins, $9.2 Billion Cidara Deal and Fresh Highs — November 29, 2025

Published: November 29, 2025 Merck & Co., Inc. (NYSE: MRK) heads into the last month of 2025 riding a powerful wave of oncology wins, big‑ticket acquisitions and fresh analyst upgrades that have pushed the stock to new 52‑week highs. As

29 November 2025

Exact Sciences (EXAS) Stock Today: Analyst Downgrades, Abbott’s $21 Billion Takeover and Legal Scrutiny – 25 November 2025

Exact Sciences Corporation (NASDAQ: EXAS) is trading near record highs as Wall Street shifts to “Hold,” merger-arb funds move in and shareholder lawyers start circling Abbott’s $21 billion bid. Exact Sciences Stock Price Snapshot for 25 November 2025 On Tuesday,

25 November 2025

Analyst Downgrades · Healthcare Stocks · Legal Issues · Mergers and Acquisitions · NASDAQ:EXAS · NYSE:ABT · Stock Analysis

Exact Sciences (EXAS) Stock Today, November 24, 2025: Abbott Buyout Spread, Analyst Downgrades and UBS Target Hike

Dateline: November 24, 2025 Exact Sciences Corporation (NASDAQ: EXAS) stock is trading calmly near its takeover price today as Wall Street digests a flood of fresh analyst calls, legal scrutiny and local reaction to Abbott Laboratories’ multi‑billion‑dollar bid for the

24 November 2025

Analyst Ratings · Healthcare Stocks · Investment Strategies · Mergers and Acquisitions · NASDAQ:EXAS · NYSE:ABT · Stock Market News

MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

Molina Healthcare Inc. (NYSE: MOH) shares bounced higher on Monday as traders reacted to fresh headlines about a possible extension of Affordable Care Act (ACA) subsidies, even as the managed-care insurer continues to grapple with margin pressure, new class‑action lawsuits

24 November 2025

ACA News · Health Policy · Healthcare Stocks · Molina Healthcare · NYSE:MOH · Stock Market Analysis

Hims & Hers Health (HIMS) Stock Today, November 23, 2025: Price, Buyback and GLP‑1 Risks

Hims & Hers Health (NYSE: HIMS) heads into the new week as one of the market’s most closely watched telehealth and weight‑loss plays — but also one of its most volatile. After Friday’s session (21 November 2025), HIMS closed at

23 November 2025

Financial Analysis · GLP-1 Drugs · Healthcare Stocks · Investing · Stock Market

EXAS Stock Soars on Abbott Takeover Talks: Exact Sciences Jumps Over 20% on November 19, 2025

Exact Sciences Corporation (NASDAQ: EXAS) is surging today after reports that healthcare giant Abbott Laboratories is in advanced talks to acquire the cancer diagnostics specialist. Shares of EXAS spiked sharply intraday, briefly approaching new 52‑week highs as traders rushed into

19 November 2025

Financial Analysis · Healthcare Stocks · Investment News · Mergers & Acquisitions · Stock Market

Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Stock Hits All-Time High After Earnings Surprise Cardinal Health’s stock price surged to an all-time high on October 30, 2025, after the company delivered much better-than-expected quarterly results. Shares soared ~13% in one day, briefly trading above $190 intraday and

30 October 2025

Earnings Reports · Financial Analysis · Healthcare Stocks · Investment News · NYSE:CAH · Stock Market

Molina Healthcare (MOH) Stock Plunges 18% on Earnings Shock – What’s Next?

Q3 Earnings Shock Triggers Selloff Molina Healthcare’s third-quarter earnings report sparked a major selloff in its stock this week. The Medicaid and Obamacare-focused insurer delivered adjusted Q3 earnings of just $1.84 per share, far below analyst expectations of around $3.90

23 October 2025

Earnings Reports · Financial News · Healthcare Stocks · Investment Analysis · NYSE:MOH · Stock Market

Intuitive Surgical (ISRG) Stock Explodes 17% on Q3 Blowout – Is $600 Next?

Q3 Earnings Blowout and Stock Reaction Intuitive Surgical crushed expectations for the quarter ended Sept 30, 2025. 3Q revenue was $2.51 billion, up 23% from a year ago, versus analyst forecasts of ~$2.40 billion reuters.com. Adjusted EPS came in at $2.40 (GAAP

22 October 2025

Earnings Reports · Financial News · Healthcare Stocks · Investing · NASDAQ:ISRG · Stock Market

Intuitive Surgical Stock Primed for Rally on FDA Approvals and Congressional Buying

Stock Performance & Analyst Consensus Intuitive’s stock has been volatile in 2025. It gained ground last week on optimism (e.g. up ~2.7% on Oct. 17) and now sits around $446 investing.com marketbeat.com. Over the past year, the price swung between

19 October 2025

FDA Approvals · Healthcare Stocks · Investment Strategies · Medical Technology · NASDAQ:ISRG · Stock Market

Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Price and Performance Abbott’s stock has been trading in a tight range around $128–$133 in mid-October 2025. On Oct 15, the price was about $128 – down 3.5% intraday reuters.com. Over the past few trading days ABT fell from $131.38

15 October 2025

Earnings Reports · Financial Analysis · Healthcare Stocks · Investing · NYSE:ABT · Stock Market

Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Skyrockets – Major News & Analyst Insights (Oct 2025)

Key Facts: Oscar Health’s stock recently jumped to roughly $21.5 on Oct 3, 2025 (up ≈11% that day) indmoney.com. Over the past week, the stock is up about 8% marketscreener.com. In Q2 2025, Oscar reported $2.9 billion revenue (+28–30% YoY) but

3 October 2025

Analyst Insights · Financial News · Healthcare Stocks · Investments · NYSE:OSCR · Stock Market

Healthcare Stocks News 3 October 2025 - 29 November 2025